Subtype
Malignant Colorectal Neoplasm
CI-CAN-00005874Explore in graph →
1,565 active trials21 approved drugs382 evidence items
- NCIt
- C4978
- DOID
- 9256
- Other
- 1 more code
Loading cancer entity…
Subtype
CI-CAN-00005874Explore in graph →
Clinical trials
7,296 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (722)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03465202 | Association of Capecitabine Pharmacokinetics and Toxicity With Aging | unknown | Phase 4 | 100 | Newcastle-upon-Tyne Hospitals NHS TrustOTHER | 0 | Mar 14, 2018 | clinicaltrials |
| NCT03462992 | Peripheral Blood Monocytes as Predictive Marker for Colorectal Cancer Diagnosis: A Comparative Study of a Stool Based Versus Blood Based Screening Test(MonoFIT+) | unknown | — | 250 | DNAlyticsINDUSTRY | 1 | Mar 13, 2018 |
| clinicaltrials |
| NCT01196260 | Combination Chemotherapy Treatments in Patients With Colorectal Cancer Stage II and III | unknown | Phase 2 / Phase 3 | 8,000 | State Key Laboratory of Cancer BiologyNETWORK | 1 | Feb 20, 2018 | clinicaltrials |
| NCT02215642 | Nutrition and Lifestyle Study Cohort of Colorectal Cancer in China | unknown | — | 50,000 | State Key Laboratory of Cancer BiologyNETWORK | 1 | Feb 20, 2018 | clinicaltrials |
| NCT03435666 | A Bioequivalence Study of Capecitabine Tablets 500 mg in Adult Cancer Patients Under Fed Condition(Capecitabine) | unknown | Phase 1 | 45 | Qilu Pharmaceutical Co., Ltd.INDUSTRY | 0 | Feb 19, 2018 | clinicaltrials |
| NCT02296203 | Cetuximab Rechallenge in Irinotecan-pretreated mCRC, KRAS, NRAS and BRAF Wild-type Treated in 1st Line With Anti-EGFR Therapy (CRICKET).(CRICKET) | unknown | Phase 2 | 27 | Gruppo Oncologico del Nord-OvestOTHER | 1 | Feb 15, 2018 | clinicaltrials |
| NCT03434925 | Multi Parametric Test Predicting the Risk of Colorectal Neoplasia Recurrence | unknown | N/A | 200 | Military University Hospital, PragueOTHER | 1 | Feb 15, 2018 | clinicaltrials |
| NCT03431428 | Comparison of Short-term Efficacy and Long-term Prognosis for Reduction Surgery and Radical Resection in Almost-cCR Rectal Cancer Patients | unknown | Phase 3 | 477 | Zhang RuiOTHER | 1 | Feb 13, 2018 | clinicaltrials |
| NCT03355391 | Characterization of Brazilian Colorectal Cancer Screening Population | unknown | — | 2,000 | Barretos Cancer HospitalOTHER | 0 | Feb 1, 2018 | clinicaltrials |
| NCT03416478 | The Implication of ctDNA in the Recurrence Surveillance of Stage II and III Colorectal Cancer | unknown | — | 50 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 1 | Feb 1, 2018 | clinicaltrials |
| NCT03416322 | Water-assisted Colonoscopy vs Second Forward View Examination of the Right Colon on Adenoma Detection | unknown | N/A | 708 | Barretos Cancer HospitalOTHER | 1 | Jan 31, 2018 | clinicaltrials |
| NCT03416699 | Chinese TaTME Registry Collaborative | unknown | — | 300 | Beijing Friendship HospitalOTHER | 1 | Jan 31, 2018 | clinicaltrials |
| NCT03405272 | Safety and Efficacy of Recombinant Anti-EGFR Monoclonal Antibody in Patients With Wild-type RAS and BRAF mCRC | unknown | Phase 2 | 110 | Sinocelltech Ltd.INDUSTRY | 1 | Jan 23, 2018 | clinicaltrials |
| NCT03403452 | Apatinib in the Treatment of Metastatic Colorectal Cancer | unknown | Phase 2 | 33 | Fudan UniversityOTHER | 1 | Jan 18, 2018 | clinicaltrials |
| NCT03401957 | The Emergence of RAS Mutations in Metastatic Colorectal Cancer Patients Receiving Cetuximab Treatment | unknown | — | 120 | National Health Research Institutes, TaiwanOTHER | 1 | Jan 17, 2018 | clinicaltrials |
| NCT03380858 | REINFORCEMENT ANASTOMOSIS WITH Modified Cyanacrylate IN Patients Undergoing to Oncologic Colorectal Surgery With Colorectal Anastomosis(ANASTOSEAL) | unknown | — | 390 | National Cancer Institute, NaplesOTHER | 1 | Jan 16, 2018 | clinicaltrials |
| NCT03093129 | Safety and Effectiveness Study of Pre-operative Artesunate in Stage II/III Colorectal Cancer (NeoART-V)(NeoART-V) | unknown | Phase 2 | 200 | The 108 Military Central HospitalOTHER_GOV | 1 | Jan 9, 2018 | clinicaltrials |
| NCT03393234 | Intersphincteric Resection With or Without Intraoperative Radiation in Rectal Cancer(IDAVON) | unknown | N/A | 50 | Second Hospital of Jilin UniversityOTHER | 1 | Jan 8, 2018 | clinicaltrials |
| NCT02942563 | Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer | unknown | Phase 2 | 100 | RenJi HospitalOTHER | 1 | Jan 3, 2018 | clinicaltrials |
| NCT03281070 | Anastomotic Leakage After Anterior Resection of Rectal Cancer | unknown | — | 3,000 | Beijing Friendship HospitalOTHER | 1 | Dec 28, 2017 | clinicaltrials |
| NCT03385148 | The Clinical Application of 68Ga Labeled ssDNA Aptamer Sgc8 in Healthy Volunteers and Colorectal Patients | unknown | Early Phase 1 | 70 | Xijing HospitalOTHER | 1 | Dec 28, 2017 | clinicaltrials |
| NCT03383367 | Colorectal Cancer Screening French Organizations for the Follow-up After Colonoscopy(Tempo-colo) | unknown | N/A | 33,000 | Association pour le Dépistage Organisé des Cancers dans le RhôneOTHER | 1 | Dec 26, 2017 | clinicaltrials |
| NCT03377842 | Apatinib Treatment as the Neoadjuvant Therapy in Advanced Colorectal Cancer | unknown | Phase 2 | 100 | Sichuan Provincial People's HospitalOTHER | 0 | Dec 19, 2017 | clinicaltrials |
| NCT03359616 | Transanal Versus Laparoscopic Total Mesorectal Excision For Rectal Cancer(TLTME) | unknown | N/A | 258 | Shanghai Minimally Invasive Surgery CenterOTHER | 0 | Dec 2, 2017 | clinicaltrials |
| NCT03344614 | A Study of Apatinib in Combination With Raltitrexed Treatment in Patients With Advanced Colorectal Cancer | unknown | Phase 2 | 30 | Chinese PLA General HospitalOTHER | 1 | Nov 17, 2017 | clinicaltrials |
| NCT03336229 | Enhancing Fitness With Preoperative Exercise in Colorectal Cancer Surgery(EFEx) | unknown | N/A | 72 | NHS Greater Glasgow and ClydeOTHER | 1 | Nov 8, 2017 | clinicaltrials |
| NCT03334890 | CRC Post-surgical Assessment and Recurrence Monitoring | unknown | — | 50 | BioChain (Beijing) Science and Technology, Inc.INDUSTRY | 1 | Nov 7, 2017 | clinicaltrials |
| NCT03325361 | The Role of Transanal Tube Drainage as A Mean of Prevention of Anastomotic Leakage Anastomotic Leakage | unknown | N/A | 100 | University of Rome Tor VergataOTHER | 1 | Oct 30, 2017 | clinicaltrials |
| NCT01073358 | Resection of Colorectal Liver Metastases With or Without Routine Hilar Lymphadenectomy(RELY) | unknown | N/A | 166 | Heidelberg UniversityOTHER | 1 | Oct 27, 2017 | clinicaltrials |
| NCT01348256 | Study With Dendritic Cell Immunotherapy in Resected Hepatic Metastasis of Colorectal Carcinoma | unknown | Phase 2 | 58 | Clinica Universidad de Navarra, Universidad de NavarraOTHER | 1 | Oct 24, 2017 | clinicaltrials |
| NCT03316677 | Intraoperative Testing of Colorectal Anastomosis - Air or Water (Methylene Blue)?(ITCORA) | unknown | N/A | 150 | Meir Medical CenterOTHER | 0 | Oct 20, 2017 | clinicaltrials |
| NCT02844608 | Feasibility of Quality of Life Assessment in Routine Clinical Oncology Practice at the University Hospital of Besancon(QOLIBRY) | unknown | N/A | 152 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Oct 13, 2017 | clinicaltrials |
| NCT03309722 | Molecular Pathology of Colorectal Cancer: Investigating the Role of Novel Molecular Profiles, microRNA's, and Their Targets in Colorectal Cancer Progression | unknown | — | 1,000 | University of SouthamptonOTHER | 1 | Oct 13, 2017 | clinicaltrials |
| NCT01431599 | Short-course Preoperative Chemoradiotherapy for Rectal Cancer(KROG 11-02) | unknown | Phase 2 | 80 | Jong Hoon LeeOTHER | 1 | Oct 10, 2017 | clinicaltrials |
| NCT03222557 | Electroacupuncture for Postoperative Ileus After Laparoscopic Surgery for Mid and Low Rectal Cancer | unknown | N/A | 164 | Chinese University of Hong KongOTHER | 1 | Oct 6, 2017 | clinicaltrials |
| NCT02618356 | Combined Use of Raltitrexed and S-1 as Treatment for Patients With Metastasizing Colorectal Cancer | unknown | Phase 2 | 82 | Fudan UniversityOTHER | 1 | Oct 2, 2017 | clinicaltrials |
| NCT03280407 | NEOadjuvant Chemotherapy Only Compared With Standard Treatment for Locally Advanced Rectal Cancer(NEOLAR) | unknown | Phase 2 | 124 | Zealand University HospitalOTHER | 1 | Sep 28, 2017 | clinicaltrials |
| NCT03259009 | RAS Mutations in ctDNA and Anti-EGFR reINTROduction in mCRC (RASINTRO)(RASINTRO) | unknown | — | 73 | Association des Gastroentérologues OncologuesOTHER | 0 | Sep 11, 2017 | clinicaltrials |
| NCT02746432 | Insulin Therapy Reduce Post-Operative Inflammatory Response After Curative Colorectal Cancer Resection: Randomization Controlled Trial | unknown | Phase 4 | 144 | King Saud UniversityOTHER | 1 | Aug 22, 2017 | clinicaltrials |
| NCT01716949 | Neoadjuvant Chemoradiation With 5-FU(or Capecitabine) and Oxaliplatin Combined With Hyperthermia in Rectal Cancer(HyRec) | unknown | Phase 1 / Phase 2 | 59 | University of Erlangen-Nürnberg Medical SchoolOTHER | 1 | Aug 11, 2017 | clinicaltrials |
| NCT03245203 | A Pilot Study of Neoadjuvant Chemotherapy Combined With Bevacizumab for Locally Advanced Rectal Cancer | unknown | N/A | 70 | Chinese PLA General HospitalOTHER | 1 | Aug 10, 2017 | clinicaltrials |
| NCT01308086 | Adjuvant Therapy(3 vs. 6 Months) With the FOLFOX 4 or XELOX for Stage II or Stage III Colon Cancer | unknown | Phase 3 | 2,000 | Hellenic Oncology Research GroupOTHER | 1 | Aug 9, 2017 | clinicaltrials |
| NCT02820389 | CT Colonography as the Initial Diagnostic Imaging Tool for Patients With Suspected Colorectal Cancer(CTCS) | unknown | — | 246 | Guy's and St Thomas' NHS Foundation TrustOTHER | 1 | Aug 8, 2017 | clinicaltrials |
| NCT03242187 | Trans-anal Versus Laparoscopic TME for Mid and Low Rectal Cancer(MansTaTME) | unknown | Phase 2 / Phase 3 | 30 | Mansoura UniversityOTHER | 1 | Aug 8, 2017 | clinicaltrials |
| NCT02841657 | 3D Laparoscopy Versus 2D Laparoscopy(Lap3D) | unknown | — | 350 | Casa di Cura Dott. PederzoliOTHER | 1 | Aug 7, 2017 | clinicaltrials |
| NCT03221920 | Very Low Carbohydrate Diet Effects to GPS, Serum Lactate and TNF Alpha on Colorectal Cancer | unknown | N/A | 26 | Dr. Soetomo General HospitalOTHER_GOV | 0 | Aug 1, 2017 | clinicaltrials |
| NCT03220984 | The Safety and Efficacy Test of Immuncell-LC to Treat Refractory Metastatic Colorectal Cancer | unknown | Phase 2 | 28 | Gangnam Severance HospitalOTHER | 1 | Jul 21, 2017 | clinicaltrials |
| NCT03070613 | Investigating the Use of Fluorescent Lectins to Identify Dysplasia and Cancer During Endoscopy and Surgery | unknown | Early Phase 1 | 50 | University of OxfordOTHER | 1 | Jul 18, 2017 | clinicaltrials |
| NCT03214939 | Autologous Antigen-activated Dendritic Cells in the Treatment of Patients With Colorectal Cancer | unknown | Early Phase 1 | 30 | Research Institute of Fundamental and Clinical ImmunologyOTHER_GOV | 1 | Jul 12, 2017 | clinicaltrials |
| NCT01895257 | Comparing HAI-90Y (SIR-spheres)+Chemotx LV5FU2 Versus Chemotx LV5FU2 Alone to Treat Colorectal Cancer | unknown | Phase 3 | 162 | Universiteit AntwerpenOTHER | 1 | Jul 7, 2017 | clinicaltrials |
Data updated 23 days agoSource updated Mar 14, 2018source: clinicaltrials